Merck & Co., Inc.·4

May 4, 5:43 PM ET

Guindo Chirfi 4

4 · Merck & Co., Inc. · Filed May 4, 2023

Insider Transaction Report

Form 4
Period: 2023-05-02
Guindo Chirfi
Chief Marketing Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-05-02+34,57834,578 total
    Exercise: $117.89From: 2024-05-02Exp: 2033-05-01Common Stock (34,578 underlying)
Holdings
  • Common Stock

    1,431.1
  • Common Stock-401(k) Plan

    (indirect: By 401(k))
    52.148
Footnotes (3)
  • [F1]Holdings include shares acquired in dividend reinvestment transactions.
  • [F2]Includes shares acquired and dividends earned through April 10, 2023 in the Merck U.S. Savings Plan, a 401(k) plan.
  • [F3]The option vests and becomes exercisable in equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT